12th Annual EUROHNC: the current management of head & neck cancer within a multidisciplinary framework Events, Seminars, & Publications 15. 10. 2019 The 12th Annual European Head and Neck Course was held in Amsterdam, from 9-11 October 2019 and brought together faculty members from many of the leading head and neck cancer centers from Europe and North America. The Greek delegates, Professor Ourania Nicolatou-Galitis, Professor Ioannis Sengas, Professor Timos Kyrodimos, Miltiades Trichas, Radiation Oncologist, and Vasilis Bakas, ENT Physician, all members of the Hellenic Society of Head and Neck Cancer, were happy to attend and participate in the Cours. www.eurohnc.com The experience of the faculty created a stimulating atmosphere. The excellent program covered the majority of the multidisciplinary approach, as it is needed, especially in head and neck cancer. The recent advances in diagnosis and treatment were provided with lectures and videos. Carcinogenesis, photodynamic therapy, transoral robotic surgery, function sparing radiotherapy, oropharyngeal cancers, including HPV related, were some of the main topics of the meeting. The Greek Delegation was awarded the 3rd Prize for their participation and presentation and wishes to thank the Organizers for the honor, as well as for the warm hospitality, and for offering this excellent course, which provided exceptionally high standards of education to all participants. Tags: head and neck cancer , radiotherapy , HPV , mouth cancer
Ask our experts Quality of Life 25. 07. 2025 Do you have questions about your treatment?Click HERE to ask our experts for free.Are you starting, currently undergoing, or have you completed your cancer treatment?Are you concerned about side effec...[Read more]
Osteonecrosis of the Jaws in Cancer Medications Events, Seminars, & Publications 04. 11. 2025 Following the success of the mycancer Online Seminar Series, we are pleased to invite you to the 4th WEBINAR “Osteonecrosis of the Jaws in Cancer Medications” of the 2025 series.Our goal is to promote...[Read more]
How likely are you to develop osteonecrosis of the jaw? Quality of Life 27. 06. 2025 Antiresorptive drugs help with osteoporosis and reduce bone complications in cancer patients, but they may cause osteonecrosis of the jaw (ONJ).Are you in the high-risk group?...[Read more]